|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,990 KRW | -0.17% |
|
-6.26% | -31.78% |
iNtRON Biotechnology, Inc. (KOSDAQ:A048530) announces a share repurchase program. Under the program, the company will repurchase up to KRW 3,000 million worth of its shares under the contract with KB Securities Co.,Ltd. The purpose of the program is to enhance shareholder value. The program will be valid till December 4, 2023.
As of December 1, 2022, the company had 634,659 shares in treasury within scope available for dividend and had 438 shares in treasury through other repurchase.
| 1st Jan change | Capi. | |
|---|---|---|
| -31.78% | 146M | |
| +9.83% | 115B | |
| +10.80% | 105B | |
| -10.84% | 22.71B | |
| -1.83% | 21.83B | |
| -10.77% | 18.18B | |
| -41.92% | 16.52B | |
| -15.11% | 16.01B | |
| +6.62% | 14.14B | |
| +17.53% | 10.71B |
INTRON BIOTECHNOLOGY, INC. 
